Balance Sheet Data

Regeneron Pharmaceuticals, Inc. (REGN)

$764.27

+16.80 (+2.25%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 1,409.582,809.903,214.303,5875,694.707,833.7010,353.3613,683.4618,084.6823,901.52
Total Cash (%)
Account Receivables 1,974.342,243.202,672.204,114.706,036.507,944.8310,500.2413,877.5918,341.2424,240.59
Account Receivables (%)
Inventories 726.141,151.201,415.501,916.601,951.303,492.814,616.266,101.058,063.4210,656.97
Inventories (%)
Accounts Payable 178.18218.20418.10475.50564879.731,162.691,536.662,030.922,684.15
Accounts Payable (%)
Capital Expenditure -272.63-383.10-429.60-614.60-551.90-1,125-1,486.85-1,965.08-2,597.14-3,432.50
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.